FloraVantage Control

Become a Subscriber Today!

Purchase our products with a subscription and save.
Get annualized savings, automatic renewals, delivered to you with just a few clicks—start saving now!

  • Select the subscription that best fits you
  • Largest savings when you subscribe
  • Cancel anytime
Bariatric Advantage¨ FloraVantage Capsules are formulated with a targeted probiotic, Bifidobacterium lactis B-420ª, that helps control body fat and body weight.* Guaranteed potency through expiration.
View Full Product Details
Serving size, 1 Capsule.
Select Size
Subscribe & Save
    1 Time-purchase
  • $44.50
    1 Unit Free shipping over $99
    1 +
    Out of stock!
Free Shipping on Subscriptions. Cancel Anytime.

Supplement Facts

Per Tablet Amount % Daily Value
Probiotic Blend 150mg
Lactobacillus acidophilus
Lactobacillus fermentum
Lactobacillus reuteri
Lactobacillus rhamnosus
Lactobacillus salivarius
Bifidobacterium bifidum
2.4 Billion*
*Contains at least 2.4 billion organisms per tablet at
time of manufacturing
†Daily Value not established
Serving Size: 1 Tablet
Servings Per Container: 90

Product Description

Bariatric Advantage® FloraVantage Control Capsules are formulated with a targeted probiotic, Bifidobacterium lactis B-420™, that helps control body fat and weight.* Guaranteed potency through expiration.

Featuring the clinically studied probiotic B-420™, FloraVantage Control may help support body weight regulation by modifying gut microbiota composition—leading to the production of beneficial gut metabolites and helping to improve gut integrity.1-5

FloraVantage Control is formulated with Bifidobacterium lactis B-420™, which has been shown to:5,†

  • Help control body fat*
  • Help control body weight*
  • Help reduce waist circumference*
  • Help control abdominal fat*
† Based on a six-month clinical study5 of overweight individuals taking Bifidobacterium lactis B-420™ as compared to placebo. This product should be utilized as a part of a multidisciplinary weight management plan as recommended by a healthcare practitioner. References:
1. Putaala et al., Res Microbiol 2008;159(9-10):692-698.
2. Amar et al., EMBO Mol Med 2011;3(9):559-572.
3. Stenman et al., Beneficial Microbes 2014; 5(4): 437-445.
4. Stenman et al., Diabetol Metab Syndr 2015;12(7):75.
5. Stenman et al., EBioMedicine 2016;13:190-200.